A citation-based method for searching scientific literature

T M Bryan, A Englezou, L Dalla-Pozza, M A Dunham, R R Reddel. Nat Med 1997
Times Cited: 931



Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar, G Johan Offerhaus, Roger McLendon, B Ahmed Rasheed, Yiping He, Hai Yan, Darell D Bigner, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Gregory J Riggins, Kenneth W Kinzler, Bert Vogelstein, Ralph H Hruban, Anirban Maitra, Nickolas Papadopoulos, Alan K Meeker. Science 2011
Times Cited: 613




List of shared articles



Times cited

Telomeres in toxicology: Occupational health.
Mohammad Shoeb, Helen C S Meier, James M Antonini. Pharmacol Ther 2021
0

ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
Danny MacKenzie, Andrea K Watters, Julie T To, Melody W Young, Jonathan Muratori, Marni H Wilkoff, Rita G Abraham, Maria M Plummer, Dong Zhang. Cancers (Basel) 2021
0

Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers.
Zhaoming Wang, Stephen V Rice, Ti-Cheng Chang, Yu Liu, Qi Liu, Na Qin, Daniel K Putnam, Kyla Shelton, Jennifer Q Lanctot, Carmen L Wilson,[...]. J Natl Cancer Inst 2020
2

Adult-onset neuroblastoma: Report of seven cases with molecular genetic characterization.
Kai Duan, Brendan C Dickson, Paula Marrano, Paul S Thorner, Catherine T Chung. Genes Chromosomes Cancer 2020
2

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Nathaniel J Robinson, Chevaun D Morrison-Smith, Alex J Gooding, Barbara J Schiemann, Mark W Jackson, Derek J Taylor, William P Schiemann. Life Sci Alliance 2020
3


Clinical Relevance of Alternative Lengthening of Telomeres in Cancer.
Guilherme G da Silva, Karollyne S Morais, Daniel S Arcanjo, Diêgo M de Oliveira. Curr Top Med Chem 2020
0

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Thomas Kent, Deanne Gracias, Samuel Shepherd, David Clynes. Front Oncol 2020
7

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.
Song My Hoang, Roderick J O'Sullivan. Trends Cancer 2020
9

Mechanisms that drive telomere maintenance and recombination in human cancers.
Alexander P Sobinoff, Hilda A Pickett. Curr Opin Genet Dev 2020
12

Therapeutic Targets in Telomerase and Telomere Biology of Cancers.
Rajendra Prasad, Deeksha Pal, Wajid Mohammad. Indian J Clin Biochem 2020
1

Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential.
Stina George Fernandes, Rebecca Dsouza, Gouri Pandya, Anuradha Kirtonia, Vinay Tergaonkar, Sook Y Lee, Manoj Garg, Ekta Khattar. Cancers (Basel) 2020
9

Telomere Maintenance Associated Mutations in the Genetic Landscape of Gynecological Mucosal Melanoma.
Guangwen Yuan, Jinge Song, Ning Li, Qianqian Song, Yifei Li, Yingxi Du, Xiaobing Wang, Yuchen Jiao, Lingying Wu. Front Oncol 2020
1

PML nuclear bodies and chromatin dynamics: catch me if you can!
Armelle Corpet, Constance Kleijwegt, Simon Roubille, Franceline Juillard, Karine Jacquet, Pascale Texier, Patrick Lomonte. Nucleic Acids Res 2020
6


RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
Jonathan Barroso-González, Laura García-Expósito, Song My Hoang, Michelle L Lynskey, Justin L Roncaioli, Arundhati Ghosh, Callen T Wallace, Marco de Vitis, Mauro Modesti, Kara A Bernstein,[...]. Mol Cell 2019
13

SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
Stephanie Panier, Marija Maric, Graeme Hewitt, Emily Mason-Osann, Himabindu Gali, Anqi Dai, Adam Labadorf, Jean-Hugues Guervilly, Philip Ruis, Sandra Segura-Bayona,[...]. Mol Cell 2019
23

ALTernative Functions for Human FANCM at Telomeres.
Beatriz Domingues-Silva, Bruno Silva, Claus M Azzalin. Front Mol Biosci 2019
6

Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Mindy K Graham, Jiyoung Kim, Joseph Da, Jacqueline A Brosnan-Cashman, Anthony Rizzo, Javier A Baena Del Valle, Lionel Chia, Michael Rubenstein, Christine Davis, Qizhi Zheng,[...]. Mol Cancer Res 2019
8

Telomere clustering drives ALT.
Jaewon Min, Jerry W Shay. Aging (Albany NY) 2019
1

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Nathalie Grandin, Bruno Pereira, Camille Cohen, Pauline Billard, Caroline Dehais, Catherine Carpentier, Ahmed Idbaih, Franck Bielle, François Ducray, Dominique Figarella-Branger,[...]. Acta Neuropathol Commun 2019
2

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma.
Hueng-Chuen Fan, Chuan-Mu Chen, Ching-Shiang Chi, Jeng-Dau Tsai, Kuo-Liang Chiang, Yu-Kang Chang, Shinn-Zong Lin, Horng-Jyh Harn. Int J Mol Sci 2019
15

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Mingqi Han, Christine E Napier, Sonja Frölich, Erdahl Teber, Ted Wong, Jane R Noble, Eugene H Y Choi, Roger D Everett, Anthony J Cesare, Roger R Reddel. J Cell Sci 2019
10

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.
Kathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, Marbin A Pineda, Yuelin J Zhu, Corbin D Ester, Soyeon Showman, Anna V Roschke, Joshua J Waterfall, Paul S Meltzer. Sci Rep 2019
14



ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga Vladimirova, Libo Xu, Lynnie Yang, Bin Lu,[...]. EMBO J 2019
16

How stem cells keep telomeres in check.
Julia Su Zhou Li, Eros Lazzerini Denchi. Differentiation 2018
0